Skip to main content

Research

The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.

People with diabetes who are also a part of the LGBTQ community face unique challenges when it comes to healthcare, dealing with stigma and body image issues. Shawn Laib...
Participating in clinical trials are a way for people with diabetes to be directly involved in the evolution of diabetes care. Julie Heverly shares her experience being...
The African Heritage Diet centers around traditional foods and plant-based dishes common in Africa, the Caribbean, South America, and the American South.
In a study of children younger than seven, automated insulin delivery (AID) led to greater Time in Range, less Time above Range, and lower A1C levels.
In a collaboration between ViaCyte and CRISPR Therapeutics, a new clinical trial is investigating a stem cell therapy that may eventually help millions with type 1...
Are you currently taking metformin but not meeting your A1C goals? Join a study looking to compare Rybelsus (oral semaglutide) with other oral diabetes drugs to see how...
Clinical trials are the middle step between scientific discoveries in the lab and making these discoveries available to the public. Learn how clinical trials work, the...
A new study from Stanford has found that early access to diabetes technology might lead to better health outcomes. Navigating your child’s type 1 diagnosis can be...
Five percent of people with type 2 diabetes could achieve remission, research says. In recent years, virtual clinics, coaching, and mobile apps have made achieving...
As scientific researchers continue to make strides toward a cure for type 1 diabetes, diaTribe sat down with Sean Kramer, the CEO of the Diabetes Research Institute...
For relatives of people with type 1 diabetes (T1D), about 5% have certain antibodies associated with causing T1D. By joining this clinical trial, you or your relatives...
For years, people with diabetes have sought out an accurate way to measure glucose without the need for fingersticks or fluid samples. Here’s a look at the latest in...
Time in Range (TIR) is a well established and easy to use measurement of your daily glucose management. The glycemia risk index (or dysglycemia index) is an emerging...
How can you prevent or slow the progression of diabetic neuropathy with a continuous glucose monitor (CGM)? Research shows that higher Time in Range (TIR) is associated...
Exciting new developments in diabetes research show that increasing your Time in Range can lower your risk of developing heart complications.
A follow up to the MOBILE study, which demonstrated improvements in A1C and Time in Range for continuous glucose monitoring system (CGM) users with type 2 diabetes,...
The hope of a cure for type 1 diabetes has long eluded scientific discovery. When Vertex Pharmaceuticals announced positive data from its first clinical trial...
Heart failure is one of the most common diabetes complications. New results from the EMPEROR-Preserved clinical trial show that Jardiance could be the first medication...
If you are currently taking three or more insulin injections per day, you may be eligible to participate in a clinical trial that provides you with the Guardian Connect...
The Tu Salud study showed that use of a OneTouch Verio Flex meter with the Spanish-language OneTouch Reveal app in an underserved Hispanic population led to sustained...

Pages